OBJECTIVES: This single-institution study aimed to evaluate the early to mid-term outcomes of extracardiac conduit total cavopulmonary connection (EC-TCPC).
INTRODUCTION
Since it was first described in the early 1970s [1] , the Fontan procedure has been modified several times [2, 3] , with the extracardiac conduit total cavopulmonary connection (EC-TCPC) being the most widely used Fontan modification worldwide. In Fukuoka Children's Hospital, EC-TCPC has been the procedure of choice as a Fontan modification since the mid-1990s, and we have previously reported its excellent results, as well as its superiority over intra-atrial lateral tunnel (IALT)-TCPC [4, 5] . As many patients now survive to adulthood, attention is directed towards their long-term functional clinical status and the prevalence of late morbidities specific to Fontan physiology. In this study, we summarized our 20-year single-centre experience of 500 EC-TCPC patients to provide information regarding the early to mid-term clinical outcomes of these patients, including their haemodynamic variables, cardiopulmonary exercise capacity, incidence of late-developing complications and prevalence of liver disease.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of Fukuoka Children's Hospital, and the need for individual informed consent was waived. Retrospective review of medical records including in-hospital and outpatient notes, laboratory data, cardiac catheterization and other non-invasive images, and cardiopulmonary exercise test results was performed for 500 patients who underwent EC-TCPC at Fukuoka Children's Hospital between March 1994 and March 2014. Patients who underwent EC-TCPC as a conversion from atriopulmonary connection or IALT-TCPC were excluded. In 2 patients, no follow-up data were available after hospital discharge. The patient characteristics are summarized in Table 1 . The follow-up time was defined as the time (years) between operation and the last recorded outpatient visit. Early death was defined as a death within 30 days of the operation or within the same hospitalization period.
Operation
The operation was performed via median sternotomy and standard cardiopulmonary bypass with mild hypothermia. Cardioplegic arrest was employed only when an intracardiac procedure was required. As an extracardiac conduit, an expanded polytetrafluoroethylene conduit (Gore-Tex vascular graft; W.L. Gore & Associates, Inc., Flagstaff, AZ, USA) was used in all cases. The size of the graft (number and mean body weight of the patients) was as follows: 14 mm (n = 1, 12.9 kg), 16 mm (n = 48, 11.2 ± 2.1 kg), 18 mm (n = 308, 12.8 ± 2.5 kg), 20 mm (n = 38, 26.5 ± 9.7 kg), 22 mm (n = 4, 44.1 ± 8.1 kg) and 24 mm (n = 1, 58.8 kg). In patients with inferior vena cava interruption, a conduit one size down was selected to connect the hepatic vein and pulmonary artery. In patients who had separate insertions of the inferior vena cava and hepatic vein to the atrium, these two vessels were uniforcalized and anastomosed to a conduit. Concomitant procedures were performed in 163 patients including atrioventricular valve (AVV) surgery in 55 ( plasty in 52 and replacement in 3), release of pulmonary artery stenosis in 52 (surgical in 43, intraoperative balloon and/or stenting in 9), enlargement or creation of atrial septal defect in 26, ipsilateral AVV closure in 14, Damus-Kaye-Stansel anastomosis in 11, pacemaker implantation in 6, maze and/or cryoablation in 5, release of subaortic stenosis in 4, release of pulmonary venous stenosis in 3 and others in 10 patients. Staged completion following bidirectional Glenn shunt or total cavopulmonary shunt was performed in 472 patients (94.4%). Fenestration was considered in patients with small or obstructive pulmonary arteries or elevated pulmonary vascular resistance, and was constructed when the central venous pressure was over 18 mmHg even after administration of 100% oxygen, nitric oxide and appropriate dose of inotropes upon termination of the cardiopulmonary bypass. Fenestration was performed in 6 patients (1.2%) in our series.
Postoperative management
Upon termination of cardiopulmonary bypass in the operating theatre up until extubation in the intensive care unit, inhaled nitric oxide (10-20 ppm) was administered in all cases. Low-dose nitric oxide inhalation (1-5 ppm) was continued via a nasal oxygen cannula in cases of elevated central venous pressure (>12 mmHg) and prolonged chest tube drainage (>5 days). All patients were prescribed warfarin and acetylsalicylic acid (daily dose of 2-3 mg/kg) therapy at the time of discharge. The international normalized ratio was maintained at 1.7-2.2. All patients were discharged from the hospital with home oxygen therapy and were carefully and regularly followed up by cardiologists in an outpatient setting and cardiovascular pharmacotherapy was tailored according to each patient's haemodynamic status.
Haemodynamic evaluation
The first postoperative cardiac catheterization was performed 6 months after Fontan completion to assess the haemodynamic variables, and home oxygen therapy was discontinued if central venous pressure was ≤12 mmHg. Repeat cardiac catheterization was generally considered at ages 6 (before entering elementary school), 12 (before entering junior high school) and 18 years (before transferring to the adult congenital team); however, the decision was made at the discretion of the cardiologist in charge. Standard chest radiography, transthoracic echocardiography and 12-lead electrocardiogram data were obtained during every outpatient visit, and the plasma concentration of brain natriuretic peptide (BNP) was assessed regularly. The cardiopulmonary exercise capacity was assessed using the treadmill test with the Bruce protocol in 312 patients, and the results were compared with those of age-and sex-matched healthy control subjects (n = 653).
Liver examination
The results of the serum biochemical tests, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transpeptidase (γ-GTP), total bile acid, amino-terminal type III procollagen peptide (P-III-NP) and collagen type IV levels (n = 101), and liver ultrasonography (n = 97) were reviewed in patients who were followed up for ≥ 10 years (mean interval from operation, 12.9 ± 2.8 years). 
RESULTS

Postoperative mortality
Early death occurred in 2 patients. A 2.9-year old boy with a univentricular heart who underwent concomitant AVV replacement died of ventricular failure 1.2 months after the operation. The other patient was a 1.9-year old boy with hypoplastic left heart syndrome, who died of acute respiratory distress syndrome on postoperative day 21. Late death occurred in 17 patients. The cause of death was ventricular failure in 6, infection in 4, cerebral infarction in 2, pulmonary venous obstruction in 2, gastrointestinal perforation in 1, liver cirrhosis in 1 and unknown in 1 patient. The Kaplan-Meier estimated actuarial survival rate was 96.2% at 10 years, and 92.8% at 15 years ( Fig. 1 ). In the multivariate analysis, heterotaxy was found to be the only independent predictor for postoperative mortality ( Table 2 ).
Reoperation and catheter intervention
Reoperation was performed in 22 patients, including permanent pacemaker implantation in 14, AVV replacement in 3, ligation of a major collateral artery in 3, fenestration closure in 1, aortic valve replacement in 1 and conduit exchange in 3 patients. The details of the 3 patients who underwent conduit exchange are as follows: the first patient with unbalanced atrioventricular septal defect associated with heterotaxy had developed severe AVV regurgitation and consequently underwent AVV replacement 8.9 years later. The 18-mm conduit was removed to allow atriotomy access, and replaced with a 20-mm conduit. The second patient with a double outlet right ventricle associated with heterotaxy and interruption of the inferior vena cava developed right-sided pulmonary arteriovenous fistula with progressive cyanosis. The conduit was redirected towards the right branch pulmonary artery 4.5 years later, with the aim of increasing the distribution of the hepatic venous blood to the right lung. In these 2 patients, there was no problem with the conduit itself. The third patient was with a univentricular heart with heterotaxy; in this patient, the 18-mm conduit showed progressive narrowing and was replaced with a 20-mm conduit 14 years after the initial Fontan operation. During the first postoperative catheterization, an inflection point was seen on the medial side of the conduit, where the deformity had progressed with remarkable calcification. Catheter intervention was performed in 12 patients. Of these, balloon angioplasty was performed in 5 patients and a stent was placed in 6 patients for pulmonary artery stenosis. One patient underwent balloon dilatation for recurrent coarctation at the distal aortic arch.
Late-occurring complications
New-onset tachyarrhythmia was documented in 13 patients, including supraventricular tachycardia in 10 patients, atrial flutter in 1 patient, atrial fibrillation in 1 patient and junctional ectopic tachycardia in 1 patient. New-onset bradyarrhythmia was documented in 19 patients, including sinus node dysfunction in 8 patients, atrioventricular dissociation in 5 patients, second-degree atrioventricular block in 4 patients and junctional rhythm in 2 patients. The rate of freedom from new-onset postoperative arrhythmias was 91.8% at 10 years and 89.8% at 15 years ( Fig. 2A) . Protein-losing enteropathy developed in 8 patients after a mean period of 4.8 ± 3.3 years after the operation. Systemic thromboembolism was diagnosed in 5 patients (cerebral infarction in all; the timing or suggested reason for the thromboembolic event was discontinuation or reduction of the dose of anticoagulant medicine due to bleeding complications or due to undergoing permanent pacemaker implantation in 2, patient with mechanical AVV in 1 and low medical compliance in 2 patients. No patients had any documented arrhythmia, fenestration or other right-to-left intracardiac shunting). Bleeding complications occurred in 6 patients (intracranial haemorrhage in 3, gastrointestinal bleeding in 2 and ovarian bleeding in 1 patient). Liver cirrhosis was diagnosed in 1 patient with a hypoplastic left heart syndrome variant who died 8 years after the operation. The overall rate of freedom from late-occurring complications was 89.5% at 10 years, and 81.3% at 15 years (Fig. 2B) . In the univariate analysis, age at operation was found to be the only predictor for new-onset arrhythmias (Table 2) .
Chest radiography
On the follow-up standard chest radiography, the mean cardiothoracic ratio was 46.1 ± 6.3% after a median postoperative time of 7.3 years in all patients, and the cardiothoracic ratio in 157 patients with the longer follow-up (> 10 years) was 43.5 ± 5.8%. A declining tendency in the cardiothoracic ratio was observed with increase in postoperative time (y = 50.0-0.52 × x, R = 0.42, P < 0.01).
Cardiac catheterization
Data regarding the haemodynamic variables obtained from postoperative cardiac catheterization were available for 468 patients. Data from the latest catheterization in each patient were used, and the median interval from operation was 1.1 years (mean, 3.6 ± 4.3 years). In addition, the haemodynamic variables obtained from cardiac catheterizations performed after 10 years or later (n = 53) are summarized in Table 3 . The ventricular end-diastolic pressure obtained from overall catheterization was 5.2 ± 3.3 mmHg; however, the corresponding value obtained from 53 patients ≥10 years after the operation was significantly higher than that of 433 patients obtained at <10 years after the operation (7.7 ± 3.4 vs 4.9 ± 3.1 mmHg, P < 0.01). When divided according to the morphology of the dominant ventricle, the mean end-diastolic pressure of the morphological left ventricle (n = 11) was 10.2 ± 3.8 mmHg, whereas that of the morphological right ventricle (n = 33) was 6.9 ± 3.1 mmHg and that of the morphologically undetermined ventricle (n = 9) was 7.5 ± 2.7 mmHg. Patients with the morphological left ventricle had significantly higher end-diastolic pressure than patients with the morphological right ventricle (P = 0.02).
Echocardiography
The systemic ventricular ejection fraction and the degree of AVV regurgitation were reviewed from the latest echocardiographic report (n = 486). The ejection fraction was 63.6 ± 10.6%, and 46 patients (9.5%) showed reduced systolic function (ejection fraction, <50%). AVV regurgitation was none to trivial in 290 (59.7%), mild in 152 (31.3%), moderate in 35 (7.2%) and severe in 3 (0.6%) patients. Six patients had undergone AVV replacement. When the degree of AVV regurgitation was compared by the type of AVV, the percentage of patients with AVV regurgitation (≥moderate) was higher in common AVV patients (14.8 vs 5.0%, P < 0.01).
Cardiopulmonary exercise test
The treadmill exercise test using the Bruce protocol was performed in 312 patients (mean age, 13.3 ± 5.2 years). The results were compared with those of age-and sex-matched control subjects and expressed as a percentage of normal (Table 4) . The results demonstrated nearly normal mean values of peak heart rate and peak VO 2 , indicating that the overall cardiopulmonary exercise capacity was well maintained. However, when the peak VO 2 was plotted against age at the test and time interval since the operation, significant declines were observed (R 2 = 0.32, and R 2 = 0.21, respectively) (Fig. 3) .
Basic cardiac rhythm
According to the standard 12-lead electrocardiogram obtained at the latest outpatient visit, the basic cardiac rhythm was sinus rhythm in 470 patients (96.5%), junctional rhythm in 5 patients, atrioventricular dissociation in 4 patients and pacemaker rhythm in 8 patients.
Plasma brain natriuretic peptide level
The plasma BNP concentration was measured in 480 patients for a mean period of 7.5 ± 5.0 years after the operation. In 139 patients, the level at the latest follow-up was below the reference range (<5.8 pg/ml); and, including these patients, a total of 70.4% of patients (n = 338) showed a value within the normal range (<18.5 pg/ml). Patients with residual AVV regurgitation defined as moderate or greater showed significantly higher plasma BNP levels (mean, 54.0 ± 126.1 pg/ml) than patients with mild (17.6 ± 15.3 pg/ml) and none-trivial (17.6 ± 2.2 pg/ml) AVV regurgitation, whereas the cardiothoracic ratio (R = 0.24), ventricular ejection fraction (R = 0.13) and ventricular end-diastolic pressure (R = 0.11) showed only weak correlations with plasma BNP level.
Liver examination
The results of the biochemical tests and liver ultrasonography performed in patients with a follow-up time of ≥10 years are summarized in Table 5 . In terms of the biochemical tests, a substantial number of patients showed elevated serum concentrations of γ-GTP, P-III-NP and collagen type IV. Hyper-echoic spots were detected on liver ultrasonography in 42.3% of these patients. In comparison with patients without abnormal lesions on ultrasonography, there were no differences in terms of the biochemical test results, including the P-III-NP and collagen type IV levels.
Medication
At the last outpatient visit, the proportions of prescribed medications were as follows: warfarin (n = 480, 97.8%), acetylsalicylic acid (n = 443, 90.2%), angiotensin-converting enzyme inhibitor (n = 309, 62.9%), angiotensin receptor blocker (n = 138, 28.1%), beta antagonist (n = 172, 35.0%), diuretics (n = 109, 22.2%), pulmonary vasodilator [endothelin receptor blocker (n = 29, 5.9%), phosphodiesterase type 5 inhibitor (n = 21, 4.3%), prostacyclin (n = 3, 0.6%)], and other medications such as digitalis (n = 3, 0.6%) and anti-arrhythmic agent (n = 5, 1.0%).
DISCUSSION
Several surgical modifications in the Fontan operation [2, 3] , developments in the staging strategy, and refinements in the perioperative and postoperative managements of the patients have occurred over the past four decades. With better understanding of the physiology after Fontan surgery and continuous investigation of the prevalence of late-occurring complications, the surgical outcomes of post-Fontan patients have been continuously improving [6] . In recent years, IALT-TCPC and EC-TCPC have been the most widely used modifications. We have previously compared our experiences with these two types of surgery, and found clinical advantages of EC-TCPC [4, 5] ; accordingly, EC-TCPC has been the procedure of choice at our institute since 1994. As more patients survive Fontan operation and grow into adolescence and adulthood, our concern has been focused on their late outcomes. Many investigations have been performed to clarify the late morbidities associated with Fontan physiology, including the risks of atrial arrhythmias, protein-losing enteropathy, thrombosis, exercise intolerance, and liver and ventricular dysfunctions. To our knowledge, our study is the largest single-institution study describing the early to mid-term outcomes of EC-TCPC to date. Although EC-TCPC has theoretical advantages over IALT-TCPC, concerns remain regarding the longevity of the conduit and haemodynamic deterioration related to the lack of growth ability in the Fontan pathway. In our experience, only 1 patient required a conduit exchange due to problems directly related to the conduit. In this case, the conduit was too long, and there may have been an inflection point on the medial side of the conduit at the time of operation. During the follow-up period, progressive 
CONGENITAL
T. Nakano et al. / European Journal of Cardio-Thoracic Surgerydeformity with calcification was observed, which resulted in significant obstruction of the Fontan pathway. Although some other patients also showed calcification in the conduit, no obstruction was seen in these patients. With regard to the geometrical changes in the Fontan pathway over time, we have previously demonstrated that the diameter of the pulmonary artery and length of the inferior vena cava above the hepatic vein insertion grow similarly to compensate for the lack of growth of the conduit [7] . Another major concern is the appropriate size of the conduit. Itatani et al. [8] investigated the optimal size of the conduit in EC-TCPC using a computational haemodynamic simulation model, and suggested that a 16-or 18-mm conduit is sufficient for the Fontan pathway. Indeed, in this study, patients with a 16-mm conduit showed satisfactory and comparable results to patients with larger conduits, and we believe that an 18-mm conduit is large enough for the average Japanese adult population. Atrial arrhythmia has been known to significantly contribute to the mortality and morbidity of patients after Fontan operation. In recent reports regarding the prevalence of post-Fontan arrhythmias, reduced risks of developing new-onset arrhythmias, likely due to the surgical modifications and improvements in the post-Fontan management, have been reported. Stephenson et al. [9] showed in their multicentre study of 520 patients that the prevalence of intra-atrial re-entry tachycardia was 7.3% during a mean follow-up of 8.6 years, and the incidence rates were found to be similar between IALT-TCPC (6%) and EC-TCPC (2%). The authors moreover demonstrated that the hazard increased with age after 6 years post-Fontan. Similarly, Lasa et al. [10] reported a lower prevalence of arrhythmias late after Fontan compared with previous series. In their report, the prevalence of late tachyarrhythmias was comparable between EC-TCPC and IALT-TCPC (3 vs 4%). On the other hand, late bradyarrhythmias were relatively frequently observed (29% in EC-TCPC and 31% in IALT-TCPC). The authors concluded that the prevalence of arrhythmias after contemporary Fontan modification was low, and that a longer time after Fontan surgery was a risk factor for late pacemaker implantation, whereas we found that age at operation was a risk factor for post-Fontan arrhythmias. While the cause of atrial arrhythmia after Fontan is likely multifactorial, EC-TCPC has theoretical advantages of reducing the risk of arrhythmias, owing to avoidance of an extensive atrial suture line and exclusion of the atrium from the elevated systemic venous pressure. However, on the other hand, the risk of developing sinus node dysfunction is approximately equal to that in IALT-TCPC, owing to the fact that TCPC is performed as a multistage surgery. The prevalence of tachyarrhythmias in this study (2.6%) is comparable to that of previous studies, and the overall post-Fontan arrhythmia-free rates (91.8% at 10 years and 89.8% at 15 years) were considered quite satisfactory considering the high rate of heterotaxy in our patients.
Thrombosis remains one of the major complications after Fontan operation, and the underlying physiology and clinical status of the patients are known to be associated with an increased risk of thrombus formation after Fontan surgery [11] . The necessity and efficacy of antithrombotic therapy are somewhat controversial [12, 13] ; however, we want to emphasize the importance of antithrombotic therapy in post-Fontan patients, as a recent study revealed abnormalities in coagulation factors and inhibitors, enhanced platelet activation and endothelial injury in post-Fontan adult patients, and the net effect of all these abnormalities tilt the balance towards a prothrombotic state [14] . In addition, asymptomatic pulmonary emboli have been reported in 17% of Fontan patients [15] , and recurrent small thromboembolisms in the pulmonary circulation may increase the pulmonary vascular resistance and result in deterioration of the Fontan circulation. However, the appropriate treatment protocol is currently unknown. The report from the Fontan Anticoagulation Study Group showed that the efficacy of isolated warfarin (international normalization ratio: 2.0-3.0) or Relationship between the percentage of the predicted peak oxygen consumption ( peak VO 2 ) and age of the patients at the cardiopulmonary exercise test (A), and time interval from operation (B). There was a decline in the value with increased age at the test (R 2 = 0.32) and elapsed time since operation (R 2 = 0.21). acetylsalicylic acid (5 mg/kg/day) was suboptimal in preventing thrombosis [13] . Whether our current prophylactic protocol is appropriate is difficult to determine, as we do not perform routine trans-esophageal echocardiography in our institution, which is regarded as a sensitive modality for detecting thrombi in the Fontan pathway in asymptomatic patients [16] . Although we set a rough target range of an international normalization ratio of 1.7-2.2, the appropriate target range should be individually determined, especially in patients with episodes of thrombosis. Recently, liver complications, including fibrosis, cirrhosis and cellular carcinoma have been increasingly reported in post-Fontan patients; however, the prevalence, pathogenesis and prognosis of these complications are unknown [17, 18] . In the present study, when focusing on patients with a follow-up time of ≥10 years, although the results of most routine liver biochemical tests, such as AST and ALT levels, were within the reference ranges, a substantial number of patients showed abnormally elevated values of P-III-NP and collagen type IV, which are sensitive serum markers for liver fibrosis [19] ; however, we did not find any haemodynamic variables that correlated with these elevated values. In addition, liver ultrasonography revealed hyper-echoic spots of varying size and number in 42.3% of these patients, and these may reflect the areas of liver fibrosis. The diagnosis and degree of progression of liver fibrosis are difficult to determine, as abnormal findings on liver ultrasonography do not necessarily correlate with the serum levels of liver fibrosis markers. In terms of the diagnostic modality, a recent report described the efficacy of transient elastography in assessing congestive liver disease [18] . Although liver fibrosis in post-Fontan patients has been suggested to be the result of long-time exposure to congestion and elevated pressure of the systemic vein, and representative of low cardiac output in Fontan physiology, the long-term effects of persistent fenestration on liver function have not yet been well investigated. Camposilvan et al. [20] found that liver dysfunction correlated with reduced cardiac index in post-Fontan patients; however, they also found that the presence of an open fenestration did not correlate with the degree of liver dysfunction. However, the number of patients in their report was relatively small; and thus, whether fenestration could prevent or delay the development of liver disease remains unknown and requires further investigation.
Although the Fontan circulation seemed to be sufficiently maintained with low central venous pressure even 10 years after the operation in this study, the elevated value of ventricular enddiastolic pressure observed remains a concern. We speculate that ventricular diastolic dysfunction after Fontan operation is multifactorial, with ventricular fibrosis representing a potential cause [21] ; this may be induced and stimulated by chronic exposure to increased wall stress in the abnormally structured single ventricle. We also speculate that if the ventricular preload tends to decrease over time after Fontan operation, the ventricular volume/mass ratio will also decrease with time. Indeed, the cardiothoracic ratio upon chest radiography showed a tendency to decrease with time in the current study. This change in the ventricular geometry may be related to the increase in ventricular stiffness and the resultant increase in the end-diastolic pressure [22] , although no significant relationship between the cardiothoracic ratio and ventricular enddiastolic pressure was observed in our patients at the current time. Further investigations are required to clarify this issue.
There have been reports describing reduced cardiopulmonary exercise capacity in post-Fontan patients [23, 24] ; however, it should be noted that the types of Fontan surgery in these studies were mostly atriopulmonary connection and IALT-TCPC. In our group of patients, the heart rate response (92.5% of the predicted value) and maximum aerobic capacity (84.9% of the predicted value) were maintained near the normal levels and were better than the corresponding values in previous reports. Although the current study demonstrated the results of cardiopulmonary exercise tests in a relatively large number of unfenestrated EC-TCPC patients, it is unknown whether the absence of fenestration may have played a part in maintaining the exercise performance in our series. On the other hand, a significant decline of the percent predicted peak VO 2 was observed along with increased age of the patients and longer time interval since operation, and this finding is consistent with those in previous reports. Paridon et al. [23] showed that adolescence was associated with a decreased percent predicted VO 2 in their cross-sectional study, and Giardini et al. [24] reported that exercise capacity progressively declined with age in Fontan subjects in their longitudinal study. While the reason for this decline is likely multifactorial, one plausible reason may be that the cardiovascular system is unable to meet the metabolic demands of the increased muscle mass during exercise as post-Fontan patients grow into adolescence and adulthood. In addition, characteristic tendency in adult Fontan patients to restrict exercise activities in daily life may reflect the low value of peak VO 2 in the cardiopulmonary exercise test.
Owing to the palliative nature of the Fontan operation, the haemodynamic status must be carefully monitored during the follow-up, including regularly repeated cardiac catheterization. We believe that the information obtained by cardiac catheterization outweighs the risk of the medical radiation. At the same time, life-long meticulous pharmacotherapy, which consists of three standard medications, namely anticoagulants, antiplatelets and cardiovascular protective agents, as well as a beta antagonist and/ or pulmonary vasodilator if indicated, must be carefully designed. Measuring the plasma BNP level on a regular basis is very important and useful in evaluating the ventricular function and efficacy of pharmacotherapy, especially in managing patients with residual AVV regurgitation or impaired ventricular function. In addition, the necessity of daily exercise must be recognized, as skeletal muscle contractions are known to play an important role in the increases in cardiac output during exercise in Fontan physiology [25] . Moreover, life-style guidance to avoid dehydration and obesity is also important to maintain good Fontan circulation.
In conclusion, the early to mid-term clinical outcomes in patients who have undergone EC-TCPC appear to be excellent, with low mortality and morbidity rates. However, the findings of this study demonstrated an increased prevalence of exercise intolerance and Fontan-associated liver disease along with increased time since Fontan completion, which implies a continuous risk of deterioration in Fontan physiology. Hence, careful long-term monitoring with appropriate, individualized pharmacotherapy is essential.
